Canada Consults On Real-World Evidence Guidance For HTAs And Regulators
Executive Summary
Canada’s health technology appraisal body is seeking feedback on guidance on the use of real-world evidence in decision making.
You may also be interested in...
Canada Launches ‘More Responsive’ Post-Marketing Drug Evaluation Program
Canada’s health technology appraisal body, CADTH, has launched a new program that will harness real-world evidence to provide more information and advice on the safety and effectiveness of drugs that are already approved.
UK Industry Urges Government To Drop Statutory Pricing Scheme Rate Hike
The ABPI, which represents the R&D-based pharmaceutical industry in the UK, says the proposed increase in the statutory scheme rebate sends "the worst possible signal" to global investors and boardrooms.
Proposals On EU-Wide Joint Clinical Assessments Fall Short, Warn German Industry Groups
The German pharmaceutical industry is calling for “directional correction” to the way implementation of the EU’s Health Technology Assessment Regulation is being developed.